Joseph Cosmai
Euclidean Capital Llc
Assets Managed
$392.311M
Holdings
10
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
6.19%(2Q avg: 30.71%)
Sustained Growth
2 quarters
Portfolio positions
This chart displays the top 10 holdings in Euclidean Capital Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 10 positions.
Assets under management
The assets under management (AUM) of Euclidean Capital Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 392.311M in assets, with a quarterly growth rate of 6.19% and a 2-quarter average growth rate of 30.71%. The portfolio is managed by Joseph Cosmai, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
VEU Vanguard Ftse All-world Ex-u
| 62.09% | $243.586M 3.243M shares@ $75.1 avg price | Increased 8.48% |
VTV Vanguard Value Etf
| 26.01% | $102.024M 520,000 shares@ $196.2 avg price | |
INDA Ishares Msci India Etf
| 4.42% | $17.312M 369,600 shares@ $46.84 avg price | |
ORIC Oric Pharmaceuticals Inc
| 3.2% | $12.536M 989,410 shares@ $12.68 avg price | |
FHTX Foghorn Therapeutics Inc
| 1.92% | $7.523M 1.574M shares@ $4.79 avg price | |
PMVP Pmv Pharmaceuticals Inc
| 0.84% | $3.258M 2.628M shares@ $1.24 avg price | |
ALEC Alector Inc
| 0.72% | $2.812M 1.308M shares@ $2.16 avg price | |
SRZN Surrozen Inc
| 0.66% | $2.555M 87,696 shares@ $29.13 avg price | |
TNYA Tenaya Therapeutics Inc
| 0.18% | $703,274 1.016M shares@ $0.7 avg price | |
SRZNW Surrozen Inc-cw25
| 0.01% | $2,733 170,833 shares@ $0.02 avg price |
1-10 of 10